Here’s what you should know.
1. Allergan reported earnings per share of $3.90 for its fourth quarter, beating analysts’ estimates of $3.76 EPS.
2. The company’s $3.86 billion in revenues for Q4 also exceeded analysts’ expectations of $3.77 billion.
3. Allergan’s stock opened at $245.68 on Feb. 10, 2017.
4. The company’s 52-week high is $301.32 and 52-week low is $184.50.
More articles on gastroenterology/endoscopy:
GI leader to know: Dr. Warren Butt of Gastroenterology Associates
Drs. Glenn Eisen, David Carr-Locke & more — 4 GI physicians in the headlines
Column: Can frozen stool replace fresh in fecal transplants? 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
